Your browser doesn't support javascript.
loading
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Jeske, Yvette W; Ali, Shamshad; Byron, Sara A; Gao, Feng; Mannel, Robert S; Ghebre, Rahel G; DiSilvestro, Paul A; Lele, Shashikant B; Pearl, Michael L; Schmidt, Amy P; Lankes, Heather A; Ramirez, Nilsa C; Rasty, Golnar; Powell, Matthew; Goodfellow, Paul J; Pollock, Pamela M.
Afiliación
  • Jeske YW; Queensland University of Technology (QUT) at the Translational Research Institute, Brisbane, Australia.
  • Ali S; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Byron SA; Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Gao F; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
  • Mannel RS; Gynecologic Oncology, The Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Ghebre RG; University of Minnesota Medical Center - Fairview, Minneapolis, MN, USA.
  • DiSilvestro PA; Gynecologic Oncology, Women and Infants Hospital, Providence, RI, USA.
  • Lele SB; Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Pearl ML; Obstetrics and Gynecology, Stony Brook University Hospital, Stony Brook, NY, USA.
  • Schmidt AP; Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA.
  • Lankes HA; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Ramirez NC; GOG Tissue Bank/NRG Oncology Biospecimen Bank - Columbus, Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Rasty G; Department of Laboratory Medicine, University of Toronto, ON, M5G2C, CANADA.
  • Powell M; Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA.
  • Goodfellow PJ; Department of Obstetrics and Gynecology, The Ohio State University and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Pollock PM; Queensland University of Technology (QUT) at the Translational Research Institute, Brisbane, Australia; Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ, USA. Electronic address: pamela.pollock@qut.edu.au.
Gynecol Oncol ; 145(2): 366-373, 2017 05.
Article en En | MEDLINE | ID: mdl-28314589
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Carcinoma Endometrioide / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Carcinoma Endometrioide / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article